• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌伴“可能浸润”是否比单纯导管原位癌更能预测浸润性癌?

Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?

机构信息

Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.

出版信息

Can Assoc Radiol J. 2012 May;63(2):146-52. doi: 10.1016/j.carj.2010.10.002. Epub 2011 May 10.

DOI:10.1016/j.carj.2010.10.002
PMID:21561735
Abstract

OBJECTIVES

To compare the underestimation of ductal carcinoma in situ (DCIS) vs DCIS with "possible invasion" at breast biopsy and to determine if any factors related to clinical indication, imaging abnormality, biopsy, or DCIS-grade affected the likelihood of underestimation.

METHODS

Of 3836 consecutive lesions that were biopsied by using a 14-gauge needle, 117 lesions revealed DCIS. Surgical pathology results of invasive carcinoma were compared with needle biopsy results of DCIS or DCIS with possible invasion. Clinical indication, imaging abnormality, biopsy guidance modality, sample number, and histologic grade were recorded. Yates corrected χ(2) and Fisher exact tests were used to determine differences between groups.

RESULTS

A total of 101 lesions were DCIS and 16 were DCIS with possible invasion at biopsy. Thirty-six of 117 lesions (31%) revealed invasive carcinoma at resection pathology. Invasive carcinoma was present more often when DCIS with possible invasion was diagnosed compared with pure DCIS (7/16 [44%] vs 29/101 [29%], P = .36). No factor, including clinical indication, imaging abnormality, biopsy guidance method, sample number, or grade, was found to significantly affect the likelihood of underestimation for lesions diagnosed as DCIS vs DCIS with "possible invasion." The likelihood of pure DCIS underestimation significantly increased when lesions were high grade compared with either intermediate or low grade (18/44 [41%] vs 9/44 [21%] vs 2/10 [20%], P = .03).

CONCLUSION

For lesions biopsied by using a 14-gauge needle, there is a trend towards underestimation of the presence of invasive carcinoma when pathology reveals DCIS with possible invasion compared with pure DCIS. High-grade DCIS was significantly more likely to be underestimated.

摘要

目的

比较在乳腺活检中,导管原位癌(DCIS)与“可能浸润”的 DCIS 的低估情况,并确定与临床指征、影像学异常、活检或 DCIS 分级相关的任何因素是否会影响低估的可能性。

方法

在连续 3836 例使用 14 号针进行活检的病变中,117 例显示为 DCIS。将浸润性癌的手术病理结果与针吸活检的 DCIS 或“可能浸润”的 DCIS 结果进行比较。记录临床指征、影像学异常、活检引导方式、样本数量和组织学分级。使用 Yates 校正 χ²和 Fisher 确切检验来确定组间的差异。

结果

共有 101 例病变为 DCIS,16 例为活检时“可能浸润”的 DCIS。117 例病变中有 36 例(31%)在切除病理中发现浸润性癌。与单纯 DCIS 相比,诊断为“可能浸润”的 DCIS 时更常出现浸润性癌(7/16 [44%] vs 29/101 [29%],P =.36)。包括临床指征、影像学异常、活检引导方法、样本数量或分级在内的任何因素均未发现显著影响诊断为 DCIS 与“可能浸润”的 DCIS 病变的低估可能性。与中、低分级相比,高分级 DCIS 的低估可能性显著增加(18/44 [41%] vs 9/44 [21%] vs 2/10 [20%],P =.03)。

结论

对于使用 14 号针活检的病变,与单纯 DCIS 相比,当病理显示“可能浸润”的 DCIS 时,存在低估浸润性癌存在的趋势。高分级 DCIS 更有可能被低估。

相似文献

1
Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?导管原位癌伴“可能浸润”是否比单纯导管原位癌更能预测浸润性癌?
Can Assoc Radiol J. 2012 May;63(2):146-52. doi: 10.1016/j.carj.2010.10.002. Epub 2011 May 10.
2
Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?经立体定向芯针活检诊断的导管原位癌:能否预测侵袭?
Radiology. 2000 Nov;217(2):466-70. doi: 10.1148/radiology.217.2.r00nv08466.
3
Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?针芯活检诊断为导管原位癌患者的前哨淋巴结活检:是否合理?
J Clin Pathol. 2009 Jun;62(6):534-8. doi: 10.1136/jcp.2008.061457. Epub 2009 Feb 3.
4
Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy.MRI引导下真空辅助乳腺活检对导管原位癌的低估
AJR Am J Roentgenol. 2007 Aug;189(2):468-74. doi: 10.2214/AJR.07.2172.
5
Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance.影像学引导下核心针活检诊断的导管原位癌升级的相关因素。
Jpn J Radiol. 2011 Oct;29(8):547-53. doi: 10.1007/s11604-011-0595-5. Epub 2011 Sep 17.
6
Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.粗针乳腺活检显示的非典型导管增生和导管原位癌:手术切除结果
AJR Am J Roentgenol. 2000 Nov;175(5):1341-6. doi: 10.2214/ajr.175.5.1751341.
7
Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients.691例纯导管原位癌的超声检查结果与临床病理及生物学特征的相关性
AJR Am J Roentgenol. 2015 Apr;204(4):878-88. doi: 10.2214/AJR.13.12221.
8
Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus.导管原位癌的超声病变大小作为术前预测浸润性病灶存在的指标。
J Surg Oncol. 2008 Jul 1;98(1):15-20. doi: 10.1002/jso.21077.
9
Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy.立体定向11号定向真空辅助乳腺活检中的钙化灶取材
Radiology. 1998 Jul;208(1):251-60. doi: 10.1148/radiology.208.1.9646821.
10
Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.超声引导下核心活检中导管原位癌低估率的比较:14 号自动核心活检针与 8 号或 11 号真空辅助活检。
Br J Radiol. 2012 Aug;85(1016):e349-56. doi: 10.1259/bjr/30974918. Epub 2012 Mar 14.

引用本文的文献

1
Breast Lesions Diagnosed as Ductal Carcinoma by Ultrasound-Guided Core Needle Biopsy: Risk Predictors for Concomitant Invasive Carcinoma and Axillary Lymph Node Metastasis.经超声引导下粗针穿刺活检诊断为导管癌的乳腺病变:伴发浸润性癌和腋窝淋巴结转移的风险预测因素
Front Oncol. 2021 Sep 10;11:717198. doi: 10.3389/fonc.2021.717198. eCollection 2021.